Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-21

Clinical Trial Update: A Trial of HRF2105 Patch in Relieving Pain of Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 trial update for HRF2105 patch intended to relieve pain in osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRF2105 patch

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Analgesia and Anti-inflammatory of Osteoarthritis | Phase 2 | Status: UNKNOWN